43
Participants
Start Date
June 21, 2022
Primary Completion Date
March 10, 2024
Study Completion Date
March 10, 2024
BX004-A
Combination of nebulized bacteriophages targeting Pseudomonas aeruginosa
Placebo
Nebulized placebo
New York Medical College, Valhalla
University Hospital in Motol, Prague
Penn State Health Milton S. Hershey Medical Center, Hershey
Children's National Medical Center, Washington D.C.
Medical University of South Carolina, Charleston
Hospital Clinico Universitario Virgen de la Arrixaca, El Palmar
University of Florida, Gainesville
Central Florida Pulmonary Group, Orlando
Joe DiMaggio Children's Hospital, Hollywood
The University of Alabama at Birmingham, Birmingham
Nationwide Children's Hospital, Columbus
University Hospitals Rainbow Babies and Children's Hospital, Cleveland
Cincinnati Children's Hospital, Cincinnati
The Chaim Sheba Medical Center, Ramat Gan
University of Arkansas for Medical Sciences, Little Rock
Baylor College of Medicine, Texas Children Clinic, Houston
University of Utah, Salt Lake City
Hadassah University Medical Center, Jerusalem
Seattle Children's Hospital, Seattle
Providence Alaska Medical Center, Anchorage
Rambam Health Care Campus (RHCC) - Ruth Rappaport Children's Hospital, Haifa
Carmel Medical Center, Haifa
Schneider Children's Medical Center of Israel, Petach Tikvah
Yale University, New Haven
Boston Children's Hospital, Boston
Amsterdam Medical Center, Amsterdam
University Medical Center Utrecht, Utrecht
Vall d'Hebron Barcelona Hospital Campus, Barcelona
BiomX, Inc.
INDUSTRY